Cello Group: Cello Group's US business fast approaching half the company

Mark Scott, chief executive of Cello Group plc (CLL) dropped into the Proactive studio to add some extra detail to the firm's interim results for the six months to June 2017. Scott said he's confident of meeting full-year market expectations after a solid first half. The Cello Health unit led the way as it grew organically and via the acquisition of Defined Health for £15mln in February, which cements its focus on the US. It also bought Advantage Health for £1.1mln after the period-end.